Allena 177-302 Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients with Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
Clinical Trial Grant
Administered By
Urology
Awarded By
Allena Pharmaceuticals
Start Date
January 15, 2021
End Date
February 28, 2026
Administered By
Urology
Awarded By
Allena Pharmaceuticals
Start Date
January 15, 2021
End Date
February 28, 2026